Jana Medical Company (TADAWUL:9616)

Jana Medical Company Statistics

Total Valuation

TADAWUL:9616 has a market cap or net worth of SAR 43.37 million. The enterprise value is 54.01 million.

Market Cap	43.37M
Enterprise Value	54.01M

Important Dates

The last earnings date was Thursday, July 10, 2025.

Earnings Date	Jul 10, 2025
Ex-Dividend Date	n/a

Share Statistics

TADAWUL:9616 has 3.21 million shares outstanding. The number of shares has increased by 3.22% in one year.

Current Share Class	3.21M
Shares Outstanding	3.21M
Shares Change (YoY)	+3.22%
Shares Change (QoQ)	+6.44%
Owned by Insiders (%)	18.01%
Owned by Institutions (%)	n/a
Float	2.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.18
PB Ratio	1.10
P/TBV Ratio	1.11
P/FCF Ratio	8.16
P/OCF Ratio	8.14
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.33
EV / Sales	1.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	10.16

Financial Position

The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.74.

Current Ratio	2.18
Quick Ratio	1.94
Debt / Equity	0.74
Debt / EBITDA	n/a
Debt / FCF	5.47
Interest Coverage	-0.68

Financial Efficiency

Return on equity (ROE) is -61.32% and return on invested capital (ROIC) is -4.75%.

Return on Equity (ROE)	-61.32%
Return on Assets (ROA)	-4.03%
Return on Invested Capital (ROIC)	-4.75%
Return on Capital Employed (ROCE)	-11.35%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.45
Inventory Turnover	9.19

Taxes

In the past 12 months, TADAWUL:9616 has paid 1.42 million in taxes.

Income Tax	1.42M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	13.92
200-Day Moving Average	22.89
Relative Strength Index (RSI)	47.49
Average Volume (20 Days)	4,584

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TADAWUL:9616 had revenue of SAR 36.71 million and -23.17 million in losses. Loss per share was -8.74.

Revenue	36.71M
Gross Profit	16.84M
Operating Income	-5.24M
Pretax Income	-21.75M
Net Income	-23.17M
EBITDA	-5.10M
EBIT	-5.24M
Loss Per Share	-8.74

Balance Sheet

The company has 18.44 million in cash and 29.08 million in debt, giving a net cash position of -10.64 million or -3.31 per share.

Cash & Cash Equivalents	18.44M
Total Debt	29.08M
Net Cash	-10.64M
Net Cash Per Share	-3.31
Equity (Book Value)	39.32M
Book Value Per Share	12.24
Working Capital	45.22M

Cash Flow

In the last 12 months, operating cash flow was 5.33 million and capital expenditures -9,491, giving a free cash flow of 5.32 million.

Operating Cash Flow	5.33M
Capital Expenditures	-9,491
Free Cash Flow	5.32M
FCF Per Share	1.65

Margins

Gross margin is 45.89%, with operating and profit margins of -14.28% and -63.13%.

Gross Margin	45.89%
Operating Margin	-14.28%
Pretax Margin	-59.26%
Profit Margin	-63.13%
EBITDA Margin	-13.90%
EBIT Margin	-14.28%
FCF Margin	14.48%

Dividends & Yields

TADAWUL:9616 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.22%
Shareholder Yield	-3.22%
Earnings Yield	-53.43%
FCF Yield	12.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TADAWUL:9616 has an Altman Z-Score of 2.39 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.39
Piotroski F-Score	5